Esperion Therapeutics just released some news that has investors celebrating and its share price soaring. The small biotech company has a medicine called bempadoic acid, which is intended to be used as an adjunct to statin therapy in patients with hypercholesterolemia. This is a state of high levels of cholesterol in the blood. Adjunct therapy … Continue reading “Esperion Therapeutics Shares Explode After This FDA News”
